Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04706520 · ClinicalTrials.gov registry record · NA
Chronic Consumption of Vinegar on Visceral Adiposity in Overweight Adults (VAnish)
A NA study, sponsored by Pennington Biomedical Research Center.
- Terminated
- Registry status
- NA
- Development phase
- 24
- Enrollment target
NCT04706520: Clinical Trial NA study, sponsored by Pennington Biomedical Research Center.
NCT04706520 is a NA study that was terminated before completion, run by Pennington Biomedical Research Center. The registered enrollment target is 24 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04706520, a NA study, was terminated before completion, sponsored by Pennington Biomedical Research Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
Study Summary
To assess, relative to a placebo, the effects of consuming 400 mL/day or 200 mL/day of a vinegar beverage providing either 1,500 mg/day of acetic acid (in two 200 mL doses daily) or 750 mg/day of acetic acid (in one 200 mL dose daily), respectively, for 12 weeks on VAT (MRI). Thus the 2 active comparator arms 400 mL and 200 mL of vinegar will be independently tested compared to placebo.
Primary Outcome
The primary objective is to assess the effects of consuming vinegar (1500mg/day and 750mg/day) on visceral adipose tissue via MRI as compared to a placebo.
Interventions
- DIETARY_SUPPLEMENT Study Beverage Consumption
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2021-02-10 |
| Est. Completion | 2021-11-04 |
| Phase | NA |
Why NCT04706520 stopped before completion
NCT04706520 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which Study Beverage Consumption is the first listed.
NCT04706520 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04706520 about?
NCT04706520 is a clinical study titled "Chronic Consumption of Vinegar on Visceral Adiposity in Overweight Adults (VAnish)". To assess, relative to a placebo, the effects of consuming 400 mL/day or 200 mL/day of a vinegar beverage providing either 1,500 mg/day of acetic acid (in two 200 mL doses daily) or 750 mg/day of acetic acid (in one 200 mL dose daily), respectively, for 12 weeks on VAT (MRI). Thus the 2 active compa...
What is the current status of trial NCT04706520?
This trial is currently terminated. It is a NA study. The enrollment target is 24 participants. The study started on 2021-02-10. Estimated completion is 2021-11-04.
What interventions are being tested in trial NCT04706520?
The interventions under investigation include: Study Beverage Consumption (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT04706520?
This trial is sponsored by Pennington Biomedical Research Center, which has 258 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04706520's enrollment target sits among peer trials
24 1736th of 2000 higher than 246 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI